American Journal of Hematology

Papers
(The H4-Index of American Journal of Hematology is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Issue Information476
267
Cytopenias revealing a case of carcinocythemia with bone marrow metastasis246
CORRIGENDUM157
Aspirin use in essential thrombocythemia: Once‐daily or twice‐daily or not at all?152
Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis147
Primary Effusion Lymphoma Prognostic Score (PEL‐PS): A Validated International Prognostic Score in HIV‐Associated Primary Effusion Lymphoma145
132
The latest insights into rare blood disorders: Diagnosis and treatment strategies114
Overall Survival in Male Patients With Advanced Hematological Disease (Mostly Acute Leukemia) Is Influenced by CYP1B1 C432G Polymorphism and Donor Sex in Allogeneic Stem Cell Transpl92
Oh node: Extranodal nodular involvement of chronic lymphocytic leukemia in the colon90
Intravenous Iron Associated Hypophosphatemia: Much More Than a Laboratory Curiosity88
Not All Tryptase Elevations Are due to Acquired Clonal Mast Cell Disorders: When Tryptase Gene Copy Number Analysis Becomes Critical84
Introduction to American Journal of Hematology Supplement: Improving Initial Care for Acute GVHD Patients84
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations78
Teclistamab in patients with multiple myeloma and impaired renal function71
The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases71
The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms70
Pediatric refractory chronic immune thrombocytopenia: Identification, patients' characteristics, and outcome67
Age defining immune effector cell associated neurotoxicity syndromes in aggressive large B cell lymphoma patients treated with axicabtagene ciloleucel66
Basiliximab for steroid‐refractory acute graft‐versus‐host disease: A real‐world analysis64
Are veterans at increased risk of myeloproliferative neoplasms?64
Antibody response to COVID‐19 mRNA vaccine (Comirnaty) in myeloma patients treated with high‐dose melphalan and/or immunotherapy61
Dendritic cell vaccines extend CAR T‐cell persistence and improve the efficacy of CD19 CAR T‐cell therapy in refractory or relapsed adult B‐ALL patients60
Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemia60
Hemolysis after high‐dose intravenous immunoglobulin: An under‐appreciated sequelae60
Clonal hematopoiesis in patients with Covid‐19 is stable and not linked to an aggravated clinical course57
Characteristics and prevalence of antibiotic allergies in patients with sickle cell disease: A single‐center retrospective study57
The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative56
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML54
Ruxolitinib for refractory large granular lymphocyte leukemia50
Muscular de‐conditioning and reduced cardiac inotropism due to iron deposition reduce exercise tolerance in beta thalassemia major49
Clonal Hematopoiesis and Thrombosis48
Natural killer cells: Innate immune system as a part of adaptive immunotherapy in hematological malignancies48
Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry data48
Acute thrombocytopenia suggesting thrombotic microangiopathy48
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia48
A t(6;14;9)(p22;q22;q34) three‐way translocation: Description of a cytogenetically visible variant t(6;9) in acute myeloid leukemia48
Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic Leukemia47
Therapeutic Errors Associated With Antithrombotic Medications Reported to United States Poison Centers46
Molecular and clinicopathologic characterization of pediatric histiocytoses46
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers45
Tocilizumab for severe acute chest syndrome in a child with sickle cell disease and dramatically high interleukin‐6 values in endotracheal and pleural fluids45
The insertion site is the main risk factor for central venous catheter‐related complications in patients with hematologic malignancies44
R‐miniCHOP versus R‐CHOP in elderly patients with diffuse large B‐cell lymphoma: A propensity matched population‐based study44
The impact of sex on platelet responses to aspirin in patients with peripheral artery disease44
0.32983899116516